0 followers
MedGene Therapeutics is focused on developing ACT treatments (PMBC derived tumor-reactive T cells-Natural Unmodified CD8+ lymphocytes) for two cancers—MSTS (metastatic soft tissue sarcoma) and MFTC (metastatic follicular thyroid cancer)—using NIH patented technology with Worldwide Exclusive License... Read more
Yong H. Park
This company has no teams yet
Merck
230 followers
Abbott
301 followers
Integrated DNA Technologies
2 followers
Orchid
1 follower
Thermo Fisher Scientific
180 followers
Gilead Sciences
136 followers
Biogen
123 followers
Regeneron
104 followers
Vertex Pharmaceuticals
66 followers
Agilent Technologies
72 followers
ADARx Pharmaceuticals
3 followers
Explore companies